NCT07310784 2026-03-03
A Phase II Trial of LM103 in Advanced Melanoma
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase 2 Recruiting
Suzhou BlueHorse Therapeutics Co., Ltd.
Swiss Cancer Institute
University of Miami
Memorial Sloan Kettering Cancer Center
Sarcoma Oncology Research Center, LLC